PTK2 and non-small cell lung carcinoma: Amygdalin inhibited the proliferation of H1299/M and PA/M NSCLC cells by 15.6% and 25.1%, respectively; it reduced the expression of integrin 1, integrin 4, FAK, p-FAK, ILK, and –catenin in the cells while increasing the expression of E-cadherin [90].